Compare HGBL & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HGBL | ABVC |
|---|---|---|
| Founded | 1937 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 50.5M |
| IPO Year | 1998 | 2009 |
| Metric | HGBL | ABVC |
|---|---|---|
| Price | $1.32 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 66.9K | 52.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.72 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $20,129,000.00 | $509,589.00 |
| Revenue This Year | $16.03 | $735.18 |
| Revenue Next Year | $5.33 | N/A |
| P/E Ratio | $14.22 | ★ N/A |
| Revenue Growth | N/A | ★ 234.31 |
| 52 Week Low | $1.21 | $0.61 |
| 52 Week High | $2.39 | $4.02 |
| Indicator | HGBL | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 19.89 |
| Support Level | $1.24 | $1.11 |
| Resistance Level | $1.47 | $1.52 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 61.29 | 16.39 |
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.